|
1
|
Jemal A, Bray F, Center MM, et al: Global
cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cha C, Fong Y, Jarnagin WR, Blumgart LH
and DeMatteo RP: Predictors and patterns of recurrence after
resection of hepatocellular carcinoma. J Am Coll Surg. 197:753–758.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shah SA, Cleary SP, Wei AC, et al:
Recurrence after liver resection for hepatocellular carcinoma: risk
factors, treatment, and outcomes. Surgery. 141:330–339. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zimmerman MA, Ghobrial RM, Tong MJ, et al:
Recurrence of hepatocellular carcinoma following liver
transplantation: a review of preoperative and postoperative
prognostic indicators. Arch Surg. 143:182–188; discussion 188.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wilusz JE, Sunwoo H and Spector DL: Long
noncoding RNAs: functional surprises from the RNA world. Genes Dev.
23:1494–1504. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tsai MC, Spitale RC and Chang HY: Long
intergenic noncoding RNAs: new links in cancer progression. Cancer
Res. 71:3–7. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang KC and Chang HY: Molecular mechanisms
of long noncoding RNAs. Mol Cell. 43:904–914. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang Z, Zhou L, Wu LM, et al:
Overexpression of long non-coding RNA HOTAIR predicts tumor
recurrence in hepatocellular carcinoma patients following liver
transplantation. Ann Surg Oncol. 18:1243–1250. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ishibashi M, Kogo R, Shibata K, et al:
Clinical significance of the expression of long non-coding RNA
HOTAIR in primary hepatocellular carcinoma. Oncol Rep. 29:946–950.
2013.PubMed/NCBI
|
|
12
|
Lai MC, Yang Z, Zhou L, et al: Long
non-coding RNA MALAT-1 overexpression predicts tumor recurrence of
hepatocellular carcinoma after liver transplantation. Med Oncol.
29:1810–1816. 2012. View Article : Google Scholar
|
|
13
|
Braconi C, Kogure T, Valeri N, et al:
microRNA-29 can regulate expression of the long non-coding RNA gene
MEG3 in hepatocellular cancer. Oncogene. 30:4750–4756. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang L, Yang F, Yuan JH, et al:
Epigenetic activation of the MiR-200 family contributes to
H19-mediated metastasis suppression in hepatocellular carcinoma.
Carcinogenesis. 34:577–586. 2013. View Article : Google Scholar
|
|
15
|
Takahashi Y, Sawada G, Kurashige J, et al:
Amplification of PVT-1 is involved in poor prognosis via apoptosis
inhibition in colorectal cancers. Br J Cancer. 110:164–171. 2014.
View Article : Google Scholar :
|
|
16
|
Guan Y, Kuo WL, Stilwell JL, et al:
Amplification of PVT1 contributes to the pathophysiology of ovarian
and breast cancer. Clin Cancer Res. 13:5745–5755. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schlaeger C, Longerich T, Schiller C, et
al: Etiology-dependent molecular mechanisms in human
hepatocarcinogenesis. Hepatology. 47:511–520. 2008. View Article : Google Scholar
|
|
18
|
Ding J, Huang S, Wu S, et al: Gain of
miR-151 on chromosome 8q24.3 facilitates tumour cell migration and
spreading through downregulating RhoGDIA. Nat Cell Biol.
12:390–399. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Edmondson HA and Steiner PE: Primary
carcinoma of the liver: a study of 100 cases among 48,900
necropsies. Cancer. 7:462–503. 1954. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Greene FL, Page DL, Fleming ID, et al:
Liver. AJCC Cancer Staging Manual. 6th edition. Springer; Chicago,
IL: pp. 4352002
|
|
21
|
Mazzaferro V, Regalia E, Doci R, et al:
Liver transplantation for the treatment of small hepatocellular
carcinomas in patients with cirrhosis. N Engl J Med. 334:693–699.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yao FY, Ferrell L, Bass NM, et al: Liver
transplantation for hepatocellular carcinoma: expansion of the
tumor size limits does not adversely impact survival. Hepatology.
33:1394–1403. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zheng SS, Xu X, Wu J, et al: Liver
transplantation for hepatocellular carcinoma: Hangzhou experiences.
Transplantation. 85:1726–1732. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gibb EA, Vucic EA, Enfield KS, et al:
Human cancer long non-coding RNA transcriptomes. PLoS One.
6:e259152011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Prensner JR, Iyer MK, Balbin OA, et al:
Transcriptome sequencing across a prostate cancer cohort identifies
PCAT-1, an unannotated lincRNA implicated in disease progression.
Nat Biotechnol. 29:742–749. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gutschner T and Diederichs S: The
hallmarks of cancer: a long non-coding RNA point of view. RNA Biol.
9:703–719. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guttman M and Rinn JL: Modular regulatory
principles of large non-coding RNAs. Nature. 482:339–346. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rinn JL, Kertesz M, Wang JK, et al:
Functional demarcation of active and silent chromatin domains in
human HOX loci by noncoding RNAs. Cell. 129:1311–1323. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tripathi V, Ellis JD, Shen Z, et al: The
nuclear-retained noncoding RNA MALAT1 regulates alternative
splicing by modulating SR splicing factor phosphorylation. Mol
Cell. 39:925–938. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Barsotti AM, Beckerman R, Laptenko O, et
al: p53-dependent induction of PVT1 and miR-1204. J Biol Chem.
287:2509–2519. 2012. View Article : Google Scholar :
|
